TREA

79404731

Follow

Information

  • Trademark
  • 79404731
  • Serial Number
    79404731
  • Filing Date
    August 07, 2024
    a year ago
  • Transaction Date
    July 24, 2025
    5 months ago
  • Status Date
    July 23, 2025
    5 months ago
  • Published for Opposition Date
    August 12, 2025
    4 months ago
  • Location Date
    July 23, 2025
    5 months ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BLACK, MILDRED
  • Attorney Name
    Kathryn M. Eyster
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of a yellow circle with two wavy lines to the left of the circle, one is dark blue and the other is larger, green and dark blue, and overlaps with the circle.
  • GS0051: Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases.
  • CC0000: The colors yellow, green, and dark blue are claimed as a feature of the mark.
Case File Event Statements
  • 9/19/2024 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 9/24/2024 - a year ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 10/16/2024 - a year ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/12/2025 - 10 months ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/16/2024 - a year ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/5/2025 - 10 months ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/13/2025 - 10 months ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/20/2025 - 9 months ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/5/2025 - 8 months ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/27/2025 - 6 months ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/27/2025 - 6 months ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/27/2025 - 6 months ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/7/2025 - 5 months ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/20/2025 - 9 months ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS